Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
4.83 USD +13.38% Intraday chart for NeuroBo Pharmaceuticals, Inc. +25.78% +30.66%
26/06 NeuroBo Pharmaceuticals, Inc. Doses First Patient in the MAD Part 2 of its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity CI
26/06 NeuroBo Pharmaceuticals Raises $20 Million from Share Placement MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEUROBO PHARMACEUTICALS, INC. Stock NeuroBo Pharmaceuticals, Inc.
 23.7M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 115B
ARGENX SE Stock argenx SE
 26.64B -
BIONTECH SE Stock BioNTech SE
 19.91B -
GENMAB A/S Stock Genmab A/S
 16.32B
  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. Charts NeuroBo Pharmaceuticals, Inc.
  5. Sector Chart